期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

结直肠癌的系统治疗 被引量：3

Systemic Therapy for Colorectal Cancer
下载PDF
导出
摘要 结直肠癌(CRC)是美国第三大常见的肿瘤,在癌症相关的死亡原因中排名第二.预计在2005年将有14.5290万例新增病例,并引起5.629万例死亡.世界范围内,CRC是第4种最常见的恶性肿瘤,估计每年新增102.3万例病人和52.9万例死亡.在本综述中,我们将讨论一些对CRC有效的较新的细胞毒化疗药物和生物制剂(表1).
作者 Jeffrey A.Meyerhardt M.P.H Robert J.Mayer 杨昌山
出处 《中国处方药》 2005年第10期23-25,共3页 Journal of China Prescription Drug
关键词 结直肠癌 系统治疗 恶性肿瘤 世界范围内 死亡原因 生物制剂 化疗药物 CRC 细胞毒
分类号 R735.3 [医药卫生—肿瘤] R749.055 [医药卫生—神经病学与精神病学]
  • 相关文献

同被引文献27

  • 1Kathryn Field,Lara Lipton.Metastatic colorectal cancer-past,progress and future[J].World Journal of Gastroenterology,2007,13(28):3806-3815. 被引量：8
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3Wendy De Roock,Bart Claes,David Bernasconi,Jef De Schutter,Bart Biesmans,George Fountzilas,Konstantine T Kalogeras,Vassiliki Kotoula,Demetris Papamichael,Pierre Laurent-Puig,Frédérique Penault-Llorca,Philippe Rougier,Bruno Vincenzi,Daniele Santini,Giuseppe Tonini,Federico Cappuzzo,Milo Frattini,Francesca Molinari,Piercarlo Saletti,Sara De Dosso,Miriam Martini,Alberto Bardelli,Salvatore Siena,Andrea Sartore-Bianchi,Josep Tabernero,Teresa Macarulla,Frédéric Di Fiore,Alice Oden Gangloff,Fortunato Ciardiello,Per Pfeiffer,Camilla Qvortrup,Tine Plato Hansen,Eric Van Cutsem,Hubert Piessevaux,Diether Lambrechts,Mauro Delorenzi,Sabine Tejpar.Effects of KRAS, BRAF, NRAS , and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis[J].Lancet Oncology.2010(8)
  • 4Michel Gonzalez,Antoine Poncet,Christophe Combescure,John Robert,Hans Beat Ris,Pascal Gervaz.Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis[J].Annals of Surgical Oncology.2013(2)
  • 5Kimmie Ng,Josep Tabernero,Jimmy Hwang,Emilio Bajetta,Sunil Sharma,Salvatore A. Del Prete,Edward R. Arrowsmith,David P. Ryan,Michaela Sedova,Jin Jin,Kamel Malek,Charles S. Fuchs.Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens[J].Clinical Cancer Research.2013(14)
  • 6Wendy De Roock,Veerle De Vriendt,Nicola Normanno,Fortunato Ciardiello,Sabine Tejpar.KRAS , BRAF , PIK3CA , and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer[J].Lancet Oncology.2011(6)
  • 7A. Silvestri,E. Pin,A. Huijbers,R. Pellicani,E. M. Parasido,M. Pierobon,E. Petricoin,L. Liotta,C. Belluco.Individualized therapy for metastatic colorectal cancer[J].J Intern Med.2013(1)
  • 8John D. Hainsworth,David M. Waterhouse,William C. Penley,Dianna L. Shipley,Dana S. Thompson,Charles D. Webb,F. Anthony Greco.Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium[J].Cancer Investigation.2013(5)
  • 9D. Mahadevan,E.G. Chiorean,W.B. Harris,D.D. Von Hoff,A. Stejskal-Barnett,W. Qi,S.P. Anthony,A.E. Younger,D.M. Rensvold,F. Cordova,C.F. Shelton,M.D. Becker,J.R. Garlich,D.L. Durden,R.K. Ramanathan.Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies[J].European Journal of Cancer.2012(18)
  • 10Takayuki Yamaguchi,Reina Kakefuda,Nobuyuki Tajima,Yoshihiro Sowa,Toshiyuki Sakai.Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor,on colorectal cancer cell lines in vitro and in vivo[J].International Journal of Oncology.2011(1)

引证文献3

二级引证文献30

中国处方药
2005年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部